The University of Alabama at Birmingham (UAB) has licensed to Illumina Inc. the rights to a DNA sequencing technology developed by a UAB microbiologist and a University of Washington physicist.
October 8, 2013, Berkeley, California – A new retail store has opened in Berkeley.
Savvy Rest Natural Bedroom specializes in nontoxic, natural and organic products for the bedroom.
“Doing good never tasted so great!” That’s the message from Panera Bread® bakery-cafés in an effort to highlight breast cancer awareness in area communities during the month of October. The annual campaign features the local sale of the Pink Ribbon Bagel -- proceeds from which will benefit breast cancer research and patient education programs at Rutgers Cancer Institute of New Jersey.
The Ohio State University today announced the signing of an exclusive world-wide agreement with Microlin Bio Inc., licensing a large portfolio of Ohio State’s groundbreaking cancer discoveries.
The field of gene therapy promises to dramatically transform the treatment of disease, as well as fundamentally change the delivery of healthcare in the twenty-first century. With an acceleration of advances taking place in the field, a new book provides a comprehensive review of the field of gene-based therapeutics in an expanded third edition textbook that concentrates on advances in areas that were in their infancy when the last edition was published in 2002.
Products that help motivate and track non-exercise activity may be eligible for NEAT product certification and to use the NEAT trademark from Mayo Clinic.
Non Exercise Activity Thermogenesis, known as NEAT™, focuses on the daily calories a person burns while doing normal, non-exercise activity.
There’s an app for that. A new iOS app developed in part by University of Kentucky researcher Elaine Wittenberg-Lyles will assist health care professionals seeking help communicating with patients during difficult conversations.
Benu BioPharma announced today the establishment of Benu BioVentures, a new biopharmaceutical investment initiative to fund and develop preclinical stage pharmaceutical investments to the human proof-of-concept stage. Leveraging Benu BioPharma's management expertise in technology commercialization and pharmaceutical development, Benu BioVentures is creating and financing virtual companies that will develop candidate drugs in a cost and time efficient manner. Funding activities will focus on product candidates with strong animal data and a clear regulatory path that address unmet medical needs. Benu BioVentures is led by Dennis Goldberg, Ph.D., FAHA and Fred Meyer, Ph.D., CFA, both recognized biopharmaceutical serial entrepreneurs.
The next generation of biometric technology launches today with the Nymi, from Bionym, a technology start-up founded by University of Toronto engineering graduates. The Nymi is the world’s first wearable authentication device that uses your unique heartbeat to unlock your identity. The convenient and secure authentication is enabled through an embedded electrocardiogram (ECG) sensor. When the Nymi recognizes your personal ECG, it will communicate your identity to your devices. You remain authenticated until the Nymi is removed. The activated Nymi can then be used to gain access to all registered devices, completely bypassing passwords and PINs for seamless and secure access. Passwords, PINs and even keys and cards will become a thing of the past.
Vaccines on the Go: What You Should Know is a unique mobile app that allows busy parents to access up-to-date, reliable information about the science and safety of vaccines -- wherever and whenever they need it. The Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) now offers the App for both iPhone and Android.
Geisinger Health System (GHS), Danville, Pa., and Holy Spirit Health System, Camp Hill, Pa., announced today the signing of a letter of intent to explore ways the healthcare organizations can work together to benefit healthcare in southcentral Pennsylvania.
Recently updated cardiac medicine (CMC) and cardiac surgery (CSC) review courses from the American Association of Critical-Care Nurses are designed to help direct-care cardiac nurses achieve subspecialty certification by reaffirming clinical knowledge and boosting their test-taking confidence.
The Johns Hopkins University Applied Physics Laboratory (APL) in Laurel, Md., and the Howard County Economic Development Authority (HCEDA) have established a technology transfer partnership to bring APL innovation to the marketplace. Howard County Executive Ken Ulman joined APL Director Ralph Semmel and HCEDA Chief Executive Officer Larry Twele as they signed the agreement and announced details of the partnership on Aug. 22.
The American Association of Critical-Care Nurses expands its growing body of evidence-based resources with a new clinical toolkit, NTI ActionPak: Strategies for Managing Alarm Fatigue. Now available online to all AACN members, NTI ActionPak is filled with evidence-based strategies, resources and best practices for reducing the threat of environmental alarms to improve patient safety and increase workplace effectiveness.
Food poisoning causes 48 million illnesses in the U.S. each year, and most recently more than 300 Midwesterners were sickened by an outbreak of cyclospora, a foodborne pathogen. The Academy of Nutrition and Dietetics encourages everyone to reduce their risk with simple safety steps from www.HomeFoodSafety.org and by downloading the free Is My Food Safe? mobile app.
NanoString is introducing an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers to independently develop multiplexed genomic assays, and then rapidly translate those assays into clinical diagnostics offered as Laboratory Developed Tests.
Rheonix, Inc. is entering into a joint development agreement with Life Technologies Corp. to introduce a molecular testing platform for their Applied Markets business.
La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin California, Inc. (KKC), a wholly-owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (KHK), a global specialty pharmaceutical company, today announced the signing of a new agreement that marks another milestone in one of the most enduring industry-academic collaborations in the world.